1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione hydrate

Catalog No. :
ACFDRO984
CAS No. :
41613-26-7
Molecular Formula :
C6H9N3O5
Molecular Weight :
203.15

IUPAC Name:1,3-dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione hydrate

1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione hydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$188.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione hydrate
IUPAC Name1,3-dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione hydrate
MDL No.MFCD00023800
Molecular FormulaC6H9N3O5
Molecular Weight203.15
SMILESO=C(N1C)N(C)C=C([N+]([O-])=O)C1=O.[H]O[H]
InChI KeyBGTJIFRRJFCEPS-UHFFFAOYSA-N
Synonym1,3-dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione | 41613-26-7 | 1,3-Dimethyl-5-nitrouracil | 1,3-dimethyl-5-nitropyrimidine-2,4-dione | 1,3-dimethyl-5-nitro-1,2,3,4-tetrahydropyrimidine-2,4-dione | 1,3-dimethyl-5-nitro-2,4(1H,3H)-pyrimidinedione | NSC70452 | EINECS 255-
CAS No.41613-26-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACFDRO984 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFDRO984 route product structure diagram
    ACFDRO98441613-26-7
Inquiry

2. ACFDRO984 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVEJM253 route compound structure diagram
    ACVEJM25328495-88-7 In Stock
  4. Then
  5. ACFDRO984 route product structure diagram
    ACFDRO98441613-26-7
Inquiry

Comments (0)